Wockhardt plunges as firm to recall drugs from US market
Wockhardt extended overnight losses and fell over 11% in intraday trade as the company announced it is recalling some drugs from the US markets that were manufactured at its Chikalthana plant in Aurangabad.
Other Corporate Videos
TCS screening candidates for C-suite rejig ahead; COO, CTO posts to be filled soon
Unicorn ed-tech firm Byju's lays off at least 1,000 more employees across various functions
Tata Trusts appoints Siddharth Sharma as CEO, Aparna Uppaluri as COO
Government to release standards for checking fake reviews on e-commerce, other platforms
Reliance retail, Adani group companies among bidders for Future Retail
